Laboratory findings

Patients (n = 60)

Control subjects

P1-value

P2-value

P3-value

Patients with episodic
and chronic migraine

TTH

Patients with hypercholesterolemia / dyslipidemia; # (%)
lipid profile
TC; mg/dl
LDL-c; mg/dl
TG; mg/dl
HDL-c; mg/dl

48 (80%)


130.20-395.00 (229.00 ± 53.15)
58.80-286.60 (141.89 ± 44.83)
48.40-423.00 (189.29 ± 11.08)
17.00-89.00 (44.52 ± 14.78)

0


130.20-195.00 (130.05 ± 48.58)
58.80-200.00 (80.56 ± 15.50)
48.40-200.00 (150.85 ± 23.56)
35.00-89.00 (39.50 ± 8.60)


0


124.00-195.00 (128.10 ± 70.10)
64.00-115.00 (57.30 ± 19.40)
49.00-128.00 (92.10 ± 8.20)
35.00-48.00 (56.90 ± 1.20)

-


0.052
0.007
0.006
0.537

-


0.675
0.432
0.001
0.113

-

0.368
0.0001
0.568
0.067

FBG; mmol/l

5.12-21.19 (10.29 ± 3.78)

5.35-10.55 (10.54 ± 3.50)

3.10-5.40 (4.30 ± 0.71)

0.0001 0.0001

0.235

Post-prandial blood glucose; mmol/l

7.00-16.00 (12.69 ± 2.39)

4.50-16.00 (12.59 ± 5.80)

4.50-6.30 (5.37 ± 0.59)

0.0001 0.0001

0.432

HbA1c

5.90-10.90 (8.11 ±1.22)

2.00-20.10 (10.50 ± 0.25)

4.00-5.70 (4.86 ± 0.48)

0.0001 0.0001

0.675

Patients with Insulin resistance; # (%)

49 (81.67%)

0

0

-

-

-

Fasting insulin; µIU/ml

2.00-35.10 (14.17 ± 10.83)

2.00-10.55 (5.56 ± 1.93)

2.00-7.20 (5.56 ± 1.93)

0.0001

0.455

0.568

Patients with hyperleptinemia; # (%)

35 (58.33%)

0

0

-

-

-

Leptin; ng/ml

1.00-106.50 (25.32 ± 7.53)

1.00-60.310 (10.60 ± 4.56)

1.00-22.10 (8.49 ± 6.62)

0.0001

0.098

0.0001

Data are expressed as mean SD; number (%)
TTH, tension type headache; FBG, fasting blood glucose; HbA1c, glycolysated hemoglobin; TC, total cholesterol; TG, triglycerides; LDL-c, low density lipoprotein cholesterol; HDL-c, high density lipoprotein cholesterol
Significance: P1: migraine versus controls; P2: TTH versus controls; P1: migraine versus TTH
Table 2: Laboratory findings of the studied groups.